Brought to you by 
Alphatec gets exclusive rights to Stout Medical's V-Stent
14 Sep 2007
Executive Summary
Under a twenty-year agreement, Stout Medical Group (minimally invasive devices for cardiovascular and orthopedic applications) licensed device company Alphatec Spine exclusive worldwide rights to develop and commercialize its V-Stent vertebroplasty technology system and implant.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com